Somnomed : Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B – 26.4.17

Appendix 4C

+Rule 4.7B

Quarterly report for entities subject to Listing Rule 4.7B

Introduced 31/03/00 Amended 30/09/01, 24/10/05, 17/12/10, 01/09/16

Name of entity
SomnoMed Limited
ABN	Quarter ended ("current quarter")
35 003 255 221	31thMarch 2017

Consolidated statement of cash flows		Current quarter $A'000	Year to date (9 months) $A'000
1.	Cash flows from operating activities	12,405	34,964
1.1	Receipts from customers
1.2	Payments for	(50)	(50)
(a) research and development
(b) product manufacturing and operating costs		(4,756)	(12,433)
(c) advertising and marketing		(1,810)	(4,516)
(d) leased assets		-	-
(e) staff costs		(4,778)	(13,464)
(f) administration and corporate costs		(2,917)	(6,596)
1.3	Dividends received (see note 3)	-	-
1.4	Interest received	39	108
1.5	Interest and other costs of finance paid	13	(4)
1.6	Income taxes paid	(11)	(832)
1.7	Government grants and tax incentives	-	-
1.8	Other (provide details if material)	-	-
1.9	Net cash from / (used in) operating activities	(1,879)	(2,823)

1. Cash flows from investing activities

2. Payments to acquire:

3. property, plant and equipment

   (395) (1,317)

4. businesses (see item 10) - -

5. investments - -

6. Consolidated statement of cash flows	Current quarter $A'000	Year to date (9 months) $A'000

7. intellectual property, licence and access rights

8. other non-current assets

1. Proceeds from disposal of:

2. property, plant and equipment

3. businesses (see item 10)

4. investments

5. intellectual property

6. other non-current assets

7. Cash flows from loans to other entities

8. Dividends received (see note 3)

9. Other (provide details if material)

2.6 Net cash from / (used in) investing activities

(2)

(212)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(103)

(103)

(500)

(1,632)

Cash flows from financing activities Proceeds from issues of shares Proceeds from issue of convertible notes Proceeds from exercise of share options Transaction costs related to issues of shares, convertible notes or options Proceeds from borrowings Repayment of borrowings Transaction costs related to loans and borrowings Dividends paid Other (provide details if material) 3.10 Net cash from / (used in) financing activities	- 16 (3) - - - - -	585 567 (54) - - - - -
	13	1,098

4. Net increase / (decrease) in cash and cash equivalents for the period

4.1 Cash and cash equivalents at beginning of quarter/year to date

16,713 17,632

4.2	Net cash from / (used in) operating activities (item 1.9 above)	(1,879)	(2,823)
4.3	Net cash from / (used in) investing activities (item 2.6 above)	(500)	(1,632)
4.4	Net cash from / (used in) financing activities (item 3.10 above)	13	1,098

Consolidated statement of cash flows		Current quarter $A'000	Year to date (9 months) $A'000
4.5	Effect of movement in exchange rates on cash held	(486)	(414)
4.6	Cash and cash equivalents at end of quarter	13,861	13,861

5.	Reconciliation of cash and cash equivalents at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts	Current quarter $A'000	Previous quarter $A'000
5.1	Bank balances	8,721	10,709
5.2	Call deposits	5,140	6,004
5.3	Bank overdrafts	-	-
5.4	Other (provide details)	-	-
5.5	Cash and cash equivalents at end of quarter (should equal item 4.6 above)	13,861	16,713

Current quarter $A'000

64

-

1. Payments to directors of the entity and their associates

2. Aggregate amount of payments to these parties included in item 1.2

3. Aggregate amount of cash flow from loans to these parties included in item 2.3

4. Include below any explanation necessary to understand the transactions included in items 6.1 and 6.2

   Payments made during the quarter include directors' fees

   Current quarter $A'000

   -

   -

5. Payments to related entities of the entity and their associates

6. Aggregate amount of payments to these parties included in item 1.2

7. Aggregate amount of cash flow from loans to these parties included in item 2.3

8. Include below any explanation necessary to understand the transactions included in items 7.1 and 7.2

   N/A

   Total facility amount at quarter end $A'000	Amount drawn at quarter end $A'000
   -	-
   -	-
   -	-

9. Financing facilities available Add notes as necessary for an understanding of the position

10. Loan facilities

11. Credit standby arrangements

12. Other (please specify)

13. Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well.

14. N/A

    9.	Estimated cash outflows for next quarter	$A'000
    9.1	Research and development	(50)
    9.2	Product manufacturing and operating costs	(5,500)
    9.3	Advertising and marketing	(2,000)
    9.4	Leased assets	-
    9.5	Staff costs	(5,000)
    9.6	Administration and corporate costs	(1,700)
    9.7	Other (provide details if material)	-
    9.8	Total estimated cash outflows	(14,250)

    10.	Acquisitions and disposals of business entities (items 2.1(b) and 2.2(b) above)	Acquisitions	Disposals
    10.1	Name of entity	N/A	N/A
    10.2	Place of incorporation or registration	N/A	N/A
    10.3	Consideration for acquisition or disposal	N/A	N/A
    10.4	Total net assets	N/A	N/A
    10.5	Nature of business	N/A	N/A